Basit öğe kaydını göster

The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey

dc.contributor.authorUzunkopru, Cihat
dc.contributor.authorÇİNAR, BİLGE PİRİ
dc.contributor.authorTÜRE, HATİCE SABİHA
dc.contributor.authorUygunoglu, Ugur
dc.contributor.authorTogrol, Rifat Erdem
dc.contributor.authorTERZİ, MURAT
dc.contributor.authorKurtuncu, Murat
dc.contributor.authorÖZAKBAŞ, SERKAN
dc.contributor.authorTutuncu, Mesude
dc.contributor.authorBECKMANN, YEŞİM
dc.contributor.authorSiva, Aksel
dc.contributor.authorGunduz, Tuncay
dc.contributor.authorSen, Sedat
dc.contributor.authorGÜMÜŞ, HALUK
dc.contributor.authorDemir, Serkan
dc.contributor.authorTutuncu, Melih
dc.date.accessioned2021-12-10T10:56:54Z
dc.date.available2021-12-10T10:56:54Z
dc.identifier.citationUzunkopru C., Tutuncu M., Gunduz T., GÜMÜŞ H., Sen S., Demir S., ÇİNAR B. P. , TÜRE H. S. , Uygunoglu U., Togrol R. E. , et al., "The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey", INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021
dc.identifier.issn1368-5031
dc.identifier.othervv_1032021
dc.identifier.otherav_5dd0ac8e-e51a-4959-b7a6-b2fdccab617b
dc.identifier.urihttp://hdl.handle.net/20.500.12627/170898
dc.identifier.urihttps://doi.org/10.1111/ijcp.14158
dc.description.abstractBackground Neuromyelitis optica spectrum disorders (NMOSD) are a group of antibody-mediated chronic inflammatory diseases of the central nervous system. Rituximab is a monoclonal antibody that leads to a reduction in disease activity.
dc.language.isoeng
dc.subjectHealth Sciences
dc.subjectDrug Guides
dc.subjectTIP, GENEL & İÇECEK
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectPharmacology
dc.subjectGeneral Pharmacology, Toxicology and Pharmaceutics
dc.subjectPharmacology, Toxicology and Pharmaceutics (miscellaneous)
dc.subjectFamily Practice
dc.subjectPharmacology (medical)
dc.subjectFundamentals and Skills
dc.subjectGeneral Health Professions
dc.subjectPathophysiology
dc.subjectPharmacy
dc.subjectInternal Medicine
dc.subjectAssessment and Diagnosis
dc.subjectMedicine (miscellaneous)
dc.subjectGeneral Medicine
dc.subjectLife Sciences
dc.titleThe efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CLINICAL PRACTICE
dc.contributor.departmentİzmir Katip Çelebi Üniversitesi , ,
dc.contributor.firstauthorID2616096


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster